Topiramate |
Formulary
|
|
|
Clonidine |
Formulary
|
|
|
Eptinezumab Vyepti® |
Formulary
|
|
NICE TA871: Eptinezumab for preventing migraine |
|
Erenumab Aimovig® |
Formulary
|
|
NICE TA682: Erenumab for preventing migraine in adults |
|
Fremanezumab Ajovy® |
Formulary
|
|
NICE TA764: Fremanezumab for preventing migraine |
|
Galcanezumab Emgality® |
Formulary
|
|
NICE TA659: Galcanezumab for preventing migraine |
|
Rimegepant Vydura® |
Formulary
|
|
NICE TA906: Rimegepant for preventing migraine NICE TA919: Rimegepant for treating migraine |
|
Botulinum Toxin Type A |
Formulary
|
|
NICE TA260: Botulinum toxin type A for the prevention of headaches in adults with chronic migraine |
|
Sodium valproate |
Formulary
|
Black Triangle in Females Valproate must no longer be prescribed to women and girls of For information relating to alerts regarding valproate, including Drug Safety Updates and links to PPP materials, please use the following link: |
Valproate medicines: Pregnancy Prevention Programme materials |
|